Robbins LLP Urges SPRY Stockholders Who Lost Money Investing in ARS Pharmaceuticals Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit
SAN DIEGO, Aug. 17, 2026 /PRNewswire/ -- Robbins LLP reminds shareholders that a securities class action has been filed on behalf...
Read moreDetails